{"transactions":[{"id":882798,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board and CEO"}}],"security":"Common Stock","published_at":"2026-02-26T01:46:08.000Z","date":"2026-02-23","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in 15 equal quarterly installments of 1,562 shares beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each of the years 2026, 2027, 2028, and 2029 and 1,570 shares vesting on March 6, 2030"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,946 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 4,152 shares vest on March 6, 2026; 4,464 shares vest on each of May 20, 2026, August 20, 2026, November 20, 2026 and March 6, 2027; 3,839 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 3,847 shares vest on March 6, 2028; 2,827 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028; 2,837 shares vest on March 6, 2029; 1,562 shares vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 1,570 shares vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date."}],"balance_after":139088,"source":{"system":"sec-edgar","filing":"0001193125-26-072717","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000119312526072717/ownership.xml","form_type":"4"}},{"id":1047154,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board and CEO"}}],"security":"Common Stock","published_at":"2025-09-05T20:15:09.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":83.53,"value":167060.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 34,098 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 4,152 shares on each of November 20, 2025 and March 6, 2026, 2,902 shares on each of May 20, 2026, August 20, 2026, November 20, 2026, and March 6, 2027, 2,277 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 2,285 shares on March 6, 2028,1,265 shares on each of  May 20, 2028, August 20, 2028, and November 20, 2028, and 1,275 shares on March 6, 2029, if he is an employee of the Company on those dates."}],"balance_after":114088,"source":{"system":"sec-edgar","filing":"0000950170-25-113254","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017025113254/ownership.xml","form_type":"4"}},{"id":1244324,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board and CEO"}}],"security":"Common Stock","published_at":"2025-02-27T01:00:07.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":20250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments of 1,265 shares vesting on each of May 20, August 20, November 20 of 2025 and March 6, May 20, August 20 and November 202 in each year 2026, 2027 and 2028, with the final 1,275 shares vesting on March 6, 2029, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the shares in footnote 1 and 22,152 shares described in next sentences. On February 24, 2025, the issuer and the reporting person mutually agreed to amend the vesting terms of the outstanding awards. Per the amendment, of the total outstanding unvested shares of 22,152, 2,887 will vest on May 20, 2025, 2,887 will vest on each August 20, 2025 and November 20, 2025, 2,887 will vest on March 6, 2026, 1,637 will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, and March 6, 2027, 1,012 will vest on each of May 20, 2027, August 20, 2027, November 2027 and 1,020 will vest on March 6, 2028, if he is employed on those dates."}],"balance_after":116088,"source":{"system":"sec-edgar","filing":"0000950170-25-028168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017025028168/ownership.xml","form_type":"4"}},{"id":1497141,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board and CEO"}}],"security":"Common Stock","published_at":"2024-05-31T22:00:04.000Z","date":"2024-05-30","kind":"sale","planned":false,"acquired":false,"shares":2900,"price":100.26,"value":290754.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported  ($100.26) is the weighted average price.  The shares were sold in multiple transactions at prices ranging from $100.00 to $100.90 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 32,913 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 3,587 shares on each of  July 1, 2024 and October 1, 2024; 3,588 shares on January 1, 2025; 2,887 shares on each April 1, 2025,  July 1, 2025, and on October 1, 2025; 2,888 shares on January 1, 2026; 1,637  shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 1,638 shares on January 1, 2027; and 1,012 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 1,017 shares on January 1, 2028, if he is an Officer of the Company on those dates."}],"balance_after":95838,"source":{"system":"sec-edgar","filing":"0000950170-24-067492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017024067492/ownership.xml","form_type":"4"}},{"id":1499625,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board and CEO"}}],"security":"Common Stock","published_at":"2024-05-29T21:27:22.000Z","date":"2024-05-29","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":100.13,"value":100130.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"For the transaction executed on May 28, 2024, the price reported ($102.13) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $102.00  to $102.26 per share, both inclusive.  For the transaction executed on May 29, 2024, the price reported ($100.13) is the weighted average price.  The shares were sold in multiple transactions at prices ranging from $100.00  to $100.49 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 32,913 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 3,587 shares on each of  July 1, 2024 and October 1, 2024; 3,588 shares on January 1, 2025; 2,887 shares on each April 1, 2025,  July 1, 2025, and on October 1, 2025; 2,888 shares on January 1, 2026; 1,637  shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 1,638 shares on January 1, 2027; and 1,012 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 1,017 shares on January 1, 2028, if he is an Officer of the Company on those dates."}],"balance_after":98738,"source":{"system":"sec-edgar","filing":"0000950170-24-066088","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017024066088/ownership.xml","form_type":"4"}},{"id":1499624,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board and CEO"}}],"security":"Common Stock","published_at":"2024-05-29T21:27:22.000Z","date":"2024-05-28","kind":"sale","planned":false,"acquired":false,"shares":1100,"price":102.13,"value":112343.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"For the transaction executed on May 28, 2024, the price reported ($102.13) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $102.00  to $102.26 per share, both inclusive.  For the transaction executed on May 29, 2024, the price reported ($100.13) is the weighted average price.  The shares were sold in multiple transactions at prices ranging from $100.00  to $100.49 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":99738,"source":{"system":"sec-edgar","filing":"0000950170-24-066088","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017024066088/ownership.xml","form_type":"4"}},{"id":1613512,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-29T01:28:43.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 16,200 shares, inclusive of those shares mentioned in note1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal installments with the first 1,012 shares on April 1, 2024 and thereafter with 1,012 shares on April 1, July 1, October 1 and Janaury 1 of each year with the final 1,017 shares lapsing on Janaury 1, 2028, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 36,500 shares, inclusive of those shares mentioned in Note 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 3,587 shares on each of April 1, 2024, July 1, 2024 and October 1, 2024; 3,588 shares on January 1, 2025; 2,887 shares on each of April 1, 2025, July 1, 2024, October 1, 2025; 2,888 shares on January 1, 2026; 1,637 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 1,638 shares on  January 1, 2027; and 1012 shares on each of April 1, 2027, July 1, 2026, October 1, 2027; and 1,017 shares on January 1, 2028, if he is an employee of the Company on those dates."}],"balance_after":100838,"source":{"system":"sec-edgar","filing":"0000950170-24-022521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000095017024022521/ownership.xml","form_type":"4"}},{"id":1997210,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-23T21:40:21.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 10,000 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 equal quarterly installments with the first 625 shares vesting on April 1, 2023 and with the final 625 shares vesting on January 1, 2027, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,204 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse as to 3,473 shares on each of April 1, 2023, July 1, 2023 and October 1, 2023;  3,485 shares on January 1, 2024; 2,575 shares on each of April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025; 1,875 shares on each of April 1, 2025, July 1, 2025, October 1, 2025; and January 1, 2026; and 625 shares on each of April 1, 2026, July 1, 2026, October 1, 2026 and January 1, 2027, if he is an employee of the Company on those dates."}],"balance_after":84638,"source":{"system":"sec-edgar","filing":"0001209191-23-012213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919123012213/doc4.xml","form_type":"4"}},{"id":2093866,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-07T19:56:07.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":5000,"price":90,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 28,333 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan.\nRestrictions lapse as to 4,129 shares on January 1, 2023; 2,848 shares on each of April 1, July 1 and October 1, 2023; 2,860 shares on January\n1, 2024; 1,950 shares on each of April 1, July 1 and October 1, 2024, and on January 1, 2025; and 1,250 shares on each of April 1, July 1 and\nOctober 1, 2025, and on January 1, 2026, if he is an employee of the Company on those dates."}],"balance_after":74638,"source":{"system":"sec-edgar","filing":"0001209191-22-060139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919122060139/doc4.xml","form_type":"4"}},{"id":2097144,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2022-12-05T20:28:57.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":10000,"price":90.01,"value":900100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price $90.01. The shares were sold in multiple transactions at prices ranging from $90.00 to $90.44 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 28,333 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse as to 4,129 shares on January 1, 2023; 2,848 shares on each of April 1, July 1 and October 1, 2023; 2,860 shares on January 1, 2024; 1,950 shares on each of April 1, July 1 and October 1, 2024, and on January 1, 2025; and 1,250 shares on each of April 1, July 1 and October 1, 2025, and on January 1, 2026, if he is an employee of the Company on those dates."}],"balance_after":79638,"source":{"system":"sec-edgar","filing":"0001209191-22-059618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919122059618/doc4.xml","form_type":"4"}},{"id":2334308,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-15T13:55:40.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 20,000 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 equal quarterly installments with the first 1,250 shares on April 1, 2022 and with the final 1,250 shares lapsing on January 1, 2026, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the 20,000 shares in Footnote 1 and includes 20,711 shares which restrictions lapse as to 2,876 on each of April 1, July 1 and October 1, 2022; 2,879 shares on January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares on January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates."}],"balance_after":89638,"source":{"system":"sec-edgar","filing":"0001209191-22-018693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919122018693/doc4.xml","form_type":"4"}},{"id":2464516,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-20T18:02:28.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":12000,"price":93.89,"value":1126680.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.75 - $94.00, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,852 shares which restrictions lapse as to 4,141 on January 1, 2022; 2,876 on each of April 1, July 1 and October 1, 2022; 2,879 shares on January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares on January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates."}],"balance_after":69638,"source":{"system":"sec-edgar","filing":"0001209191-21-070494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919121070494/doc4.xml","form_type":"4"}},{"id":2837082,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-24T17:16:04.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":11200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The  11,200 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan of which 8,800 under the Companys Discretionary Long-Term Incentive Plan for Senior Management and 2,400 as an additional grant.  Restrictions lapse in 16 equal quarterly installment with the first 700 shares on April 1, 2021 and thereafter with 700 shares on April 1, July 1, October 1 and January 1 of each year with the final 700 shares lapsing on January 1, 2025, if he is employed by the Company on those dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Inclusive of the above 11,200 shares in footnote 1, includes 37,275 shares which restrictions lapse as to 4,141 shares on each of April 1, July 1 and October 1, 2021 and January 1, 2022; 2,876 on each of April 1, July 1 and October 1, 2022; 2,879 shares on January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares on January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates."}],"balance_after":81638,"source":{"system":"sec-edgar","filing":"0001209191-21-013683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919121013683/doc4.xml","form_type":"4"}},{"id":2957141,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-04T21:56:50.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":6000,"price":106.67,"value":640020.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.64 - $107.60, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,551 shares which restrictions lapse as to 4,476 shares on January 1, 2021; 3,441 shares on each of April 1, July 1 and October 1, 2021 and January 1, 2022; 2,176 shares on each of April 1, July 1 and October 1, 2022; 2,179 shares on January 1, 2023; 898 shares on each of April 1, July 1 and October 1 2023 and 910 shares on January 1, 2024, if he is employed on those dates."}],"balance_after":70438,"source":{"system":"sec-edgar","filing":"0001209191-20-061820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919120061820/doc4.xml","form_type":"4"}},{"id":3225475,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-05T19:22:19.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":14380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 14,380 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 equal quarterly installment with the 898 shares on April 1, 2020 and thereafter with 898 shares on April 1, July 1, October 1 and January 1 of each year with the final 910 shares lapsing on January 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 43,937 shares which restrictions lapse as to 4,462 shares on each of April 1, July 1 and October 1, 2020; 4,476 shares on January 1, 2021; 3,441 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 2,176 shares on each of April 1, July 1 and October 1, 2022; 2,179 shares on January 1, 2023; 898 shares on each of April 1, July 1 and October 1 2023 and 910 shares on January 1, 2024."}],"balance_after":76438,"source":{"system":"sec-edgar","filing":"0001209191-20-016492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919120016492/doc4.xml","form_type":"4"}},{"id":3435087,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-19T22:21:19.000Z","date":"2019-08-19","kind":"sale","acquired":false,"shares":4899,"price":135.12,"value":661952.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.77 to $135.51 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 39,525 shares which restrictions lapse as to 4,984 shares on each of October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023"}],"balance_after":62058,"source":{"system":"sec-edgar","filing":"0001209191-19-046692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119046692/doc4.xml","form_type":"4"}},{"id":3435086,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-19T22:21:19.000Z","date":"2019-08-16","kind":"sale","acquired":false,"shares":1500,"price":135.07,"value":202605.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.00 to $135.31 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 39,525 shares which restrictions lapse as to 4,984 shares on each of October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023"}],"balance_after":66957,"source":{"system":"sec-edgar","filing":"0001209191-19-046692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119046692/doc4.xml","form_type":"4"}},{"id":3435085,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-19T22:21:19.000Z","date":"2019-08-15","kind":"sale","acquired":false,"shares":601,"price":135.39,"value":81369.39,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.06 to $136.22 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 39,525 shares which restrictions lapse as to 4,984 shares on each of October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023"}],"balance_after":68457,"source":{"system":"sec-edgar","filing":"0001209191-19-046692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119046692/doc4.xml","form_type":"4"}},{"id":3516037,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-22T19:43:28.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":9860,"price":120.52,"value":1188327.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.00 to $120.91 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 44,509 shares which restrictions lapse as to 4,984 shares on each of July 1, 2019, October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023."}],"balance_after":69058,"source":{"system":"sec-edgar","filing":"0001209191-19-032020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119032020/doc4.xml","form_type":"4"}},{"id":3516036,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-22T19:43:28.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":10000,"price":118.22,"value":1182200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $118.00 to $118.60 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 44,509 shares which restrictions lapse as to 4,984 shares on each of July 1, 2019, October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023."}],"balance_after":78918,"source":{"system":"sec-edgar","filing":"0001209191-19-032020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119032020/doc4.xml","form_type":"4"}},{"id":3615737,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-05T22:12:42.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":20451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 20,451 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 equal quarterly installment with the 1,278 shares on April 1, 2019 and thereafter with 1,278 on April 1, July 1, October 1 and January 1 of each year with the final 1,281 shares lapsing on January 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 49,493 shares, inclusive of the 20,451 shares in footnote 1, of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 4,984 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023."}],"balance_after":88918,"source":{"system":"sec-edgar","filing":"0001209191-19-016719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919119016719/doc4.xml","form_type":"4"}},{"id":3843914,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-15T19:31:42.000Z","date":"2018-08-14","kind":"sale","acquired":false,"shares":8768,"price":115.57,"value":1013317.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.00 - $116.65, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 41,454 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022."}],"balance_after":68467,"source":{"system":"sec-edgar","filing":"0001209191-18-046737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118046737/doc4.xml","form_type":"4"}},{"id":3850099,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-08T19:18:22.000Z","date":"2018-08-07","kind":"sale","acquired":false,"shares":451,"price":115.78,"value":52216.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.40 - $116.50, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 41,454 shares of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 6,206 shares on each of October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022."}],"balance_after":77235,"source":{"system":"sec-edgar","filing":"0001209191-18-045799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118045799/doc4.xml","form_type":"4"}},{"id":3850098,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-08T19:18:22.000Z","date":"2018-08-06","kind":"sale","acquired":false,"shares":781,"price":116.58,"value":91048.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.50 - $117.35, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 41,454 shares of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 6,206 shares on each of October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022."}],"balance_after":77686,"source":{"system":"sec-edgar","filing":"0001209191-18-045799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118045799/doc4.xml","form_type":"4"}},{"id":3937865,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-11T19:51:26.000Z","date":"2018-05-11","kind":"sale","acquired":false,"shares":2672,"price":92.16,"value":246251.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.60, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 47,660 shares of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 6,206 shares on each of July 1, 2018, October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022."}],"balance_after":78467,"source":{"system":"sec-edgar","filing":"0001209191-18-029508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118029508/doc4.xml","form_type":"4"}},{"id":3937864,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-11T19:51:26.000Z","date":"2018-05-10","kind":"sale","acquired":false,"shares":8689,"price":92.05,"value":799822.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.40, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 47,660 shares of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 6,206 shares on each of July 1, 2018, October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022."}],"balance_after":81139,"source":{"system":"sec-edgar","filing":"0001209191-18-029508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118029508/doc4.xml","form_type":"4"}},{"id":3937863,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-11T19:51:26.000Z","date":"2018-05-09","kind":"sale","acquired":false,"shares":13639,"price":92.01,"value":1254924.39,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.10, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 47,660 shares of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 6,206 shares on each of July 1, 2018, October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022."}],"balance_after":89828,"source":{"system":"sec-edgar","filing":"0001209191-18-029508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118029508/doc4.xml","form_type":"4"}},{"id":3999472,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-13T18:55:59.000Z","date":"2018-03-09","kind":"sale","acquired":false,"shares":12000,"price":86.57,"value":1038840.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.38 - $86.95, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 53,866 shares of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 6,206 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022."}],"balance_after":103467,"source":{"system":"sec-edgar","filing":"0001209191-18-019085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118019085/doc4.xml","form_type":"4"}},{"id":4009111,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-07T19:45:25.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":20240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 20,240 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 quarterly installments of 1,265 shares each beginning on April 1, 2018 and thereafter on April 1, July 1, October 1 and January 1 of each year with the final 1,265 shares lapsing on January 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the above mentioned shares and 33,626 of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 4,941 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 2,441 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: $1,021 on each of April 1, July 1 and October 1, 2020; and $1,035 on January 1, 2021."}],"balance_after":115467,"source":{"system":"sec-edgar","filing":"0001209191-18-017653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919118017653/doc4.xml","form_type":"4"}},{"id":4168176,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-11-09T17:38:54.000Z","date":"2017-11-08","kind":"sale","acquired":false,"shares":15000,"price":66.52,"value":997800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.20- $66.95, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,442 of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 6,816 shares on January 1, 2018; 4,941 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 2,441 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: $1,021 on each of April 1, July 1 and October 1, 2020; and $1,035 on January 1, 2021."}],"balance_after":95227,"source":{"system":"sec-edgar","filing":"0001209191-17-059924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919117059924/doc4.xml","form_type":"4"}},{"id":4370817,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-28T15:07:46.000Z","date":"2017-03-24","kind":"grant","acquired":true,"shares":16350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 16,350 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.  Restrictions lapse in 16 quarterly installment with the first 15 installments of 1,021 shares each beginning on April  1, 2017 and thereafter with 1,021 on April 1, July 1, October 1 and January 1 of each year with the final 1,035 shares lapsing on January 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the 16,350 shares recently granted and 44,540 of restricted stock granted under the Company's equity plans.  Restrictions lapse as to 6,816 on each of April 1, 2017, July 1, 2017, October 1, 2017 and January 1, 2018; 4,941 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 2,441 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: $1,021 on each of April 1, July 1 and October 1, 2020; and $1,035 on January 1, 2021."}],"balance_after":110227,"source":{"system":"sec-edgar","filing":"0001209191-17-023051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919117023051/doc4.xml","form_type":"4"}},{"id":4600700,"issuer":{"id":379,"kind":"organization","name":"U S PHYSICAL THERAPY INC /NV","symbol":"USPH"},"owners":[{"id":64797,"kind":"person","name":"READING CHRISTOPHER J","position":1,"cik":"0001270356","reported_name":"READING CHRISTOPHER J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-09-19T21:47:36.000Z","date":"2016-09-19","kind":"sale","acquired":false,"shares":8000,"price":64.01,"value":512080.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.00 - $64.11, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,730 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 8095 shares on October 1, 2016, January 1, 2017; 5795 on each of April 1, 2017, July 1, 2017, October 1, 2017 and January 1, 2018; 3920 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; and 1420 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020."}],"balance_after":93877,"source":{"system":"sec-edgar","filing":"0001209191-16-142057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885978/000120919116142057/doc4.xml","form_type":"4"}}]}